Prediction of Cardiac Events in Patients With Reduced Left Ventricular Ejection Fraction With Dobutamine Cardiovascular Magnetic Resonance Assessment of Wall Motion Score Index

Journal of the American College of Cardiology

Volumn 52, Issue 4, 2008, Pages 279-286

  Dall'Armellina, Erica ^a   Morgan, Timothy M ^a   Mandapaka, Sangeeta ^a   Ntim, William ^a   Carr, J Jeffrey ^a   Hamilton, Craig A ^a   Hoyle, John ^a   Clark, Hollins ^a   Clark, Paige ^a   Link, Kerry M ^a   Case, Doug ^a   Hundley, W Gregory ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac prognosis; dobutamine stress imaging; magnetic resonance imaging; myocardial ischemia

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STRESS ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS; WALL MOTION SCORE INDEX;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 46849111381     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.025     Document Type: Article

References (23)

1. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 16 (1999) 763-770
2. Hundley W.G., Hamilton C.A., Thomas M.S., et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100 (1999) 1697-1702
3. Paetsch I., Jahnke C., Ferrari V.A., et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 27 (2006) 1459-1464
4. Hundley W.G., Morgan T.M., Neagle C.M., Hamilton C.A., Rerkpattanapipat P., and Link K.M. Magnetic resonance imaging determination of cardiac prognosis. Circulation 106 (2002) 2328-2333
5. Cleland J.G., and McGowan J. Heart failure due to ischaemic heart disease: Epidemiology, pathophysiology and progression. J Cardiovasc Pharmacol 33 Suppl 3 (1999) S17-S29
6. Al-Mohammad A., Mahy I.R., Norton M.Y., et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart 80 (1998) 559-564
7. Freedman N., Schechter D., Klein M., Marciano R., Rozenman Y., and Chisin R. SPECT attenuation artifacts in normal and overweight persons: insights from a retrospective comparison of Rb-82 positron emission tomography and TI-201 SPECT myocardial perfusion imaging. Clin Nucl Med 25 (2000) 1019-1023
8. Antman E., Bassand J.P., Klein W., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol 36 (2000) 959-969
9. Mangano D.T., Browner W.S., Hollenberg M., London M.J., Tubau J.F., and Tateo I.M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 323 (1990) 1781-1788
10. Schemper M., and Smith T.L. A note on quantifying follow-up in studies of failure time. Control Clin Trials 17 (1996) 343-346
11. Yamaguchi A., Ino T., Adachi H., et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg 65 (1998) 434-438
12. Weisman H.F., Bush D.E., Mannisi J.A., Weisfeldt M.L., and Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation 78 (1988) 186-201
13. Uren N.G., Crake T., Lefroy D.C., de Silva R., Davies G.J., and Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 331 (1994) 222-227
14. Abbate A., Bussani R., Biondi-Zoccai G.G., et al. Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J 26 (2005) 2039-2045
15. Mieres J.H., Shaw L.J., Arai A., et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111 (2005) 682-696
16. Elhendy A., O'Leary E.L., Xie F., McGrain A.C., Anderson J.R., and Porter T.R. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 44 (2004) 2185-2191
17. Smart S.C., Bhatia A., Hellman R., et al. Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: Limitations and concordance. J Am Coll Cardiol 36 (2000) 1265-1273
18. Wellnhofer E., Olariu A., Klein C., et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 109 (2004) 2171-2174
19. Cigarroa C.G., deFilippi C.R., Brickner M.E., Alvarez L.G., Wait M.A., and Grayburn P.A. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88 (1993) 430-436
20. Kwong R.Y., Chan A.K., Brown K.A., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 (2006) 2733-2743
21. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006-2014
22. Hudsmith L.E., Petersen S.E., Francis J.M., Robson M.D., and Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7 (2005) 775-782
23. Edvardsen T., Rosen B.D., Pan L., et al. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging-the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 151 (2006) 109-114